Modulators of cystic fibrosis transmembrane conductance regulator
US7999113B2 · kind B2 · utility
106Cited by
0References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 11, 2006 |
| Grant date | Aug 16, 2011 |
| Priority date | — |
| Expiry date | Oct 5, 2027 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating CFTR mediated diseases using such modulators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.